The impact of platelet transfusion characteristics on posttransfusion platelet increments and clinical bleeding in patients with hypoproliferative thrombocytopenia

Blood

Volumn 119, Issue 23, 2012, Pages 5553-5562

  Triulzi, Darrell J ^a   Assmann, Susan F ^b   Strauss, Ronald G ^c   Ness, P M ^d   Hess, John R ^e   Kaufman, Richard M ^f   Granger, Suzanne ^b   Slichter, Sherrill J ^g  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b NEW ENGLAND RESEARCH INSTITUTES   (United States)

^c UNIVERSITY OF IOWA   (United States)

^d JOHNS HOPKINS UNIVERSITY   (United States)

^e UNIVERSITY OF MARYLAND   (United States)

^f BRIGHAM AND WOMEN S HOSPITAL   (United States)

^g UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ACUTE LEUKEMIA; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; BLEEDING; BLOOD COMPATIBILITY; BLOOD GROUP ABO INCOMPATIBILITY; BLOOD GROUP ABO SYSTEM; BLOOD STORAGE; CANCER CHEMOTHERAPY; CHRONIC LEUKEMIA; CONTROLLED STUDY; FEMALE; HUMAN; HYPOPROLIFERATIVE THROMBOCYTOPENIA; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MYELODYSPLASTIC SYNDROME; MYELOMA; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SOLID TUMOR; THROMBOCYTE COUNT; THROMBOCYTE PRESERVATION; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; THROMBOCYTOPHERESIS;

EID: 84862563756     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2011-11-393165     Document Type: Article

References (23)

1. Slichter SJ, Kaufman RM, Assmann SF, et al. Dose of prophylactic platelet transfusions and prevention of hemorrhage. N Engl J Med. 2010;362(7):600-613.
2. Miller AB, Hoogstraten B, Staquet M, Winkler A. Reporting results of cancer treatment. Cancer. 1981;47(1):207-214. (Pubitemid 11167383)
3. Ripatti S, Palmgren J. Estimation of multivariate frailty models using penalized partial likelihood. Biometrics. 2000;56(4):1016-1022.
4. Therneau T, Grambsch P, Pankratz VS. Penalized survival models and frailty. J Comput Graph Stat. 2003(1):12:156-175.
5. Lindstrom ML, Bates DM. Newton-Raphson and EM algorithms for linear mixed-effects models for repeated-measures data. J Am Stat Assoc. 1988;83(404):1014-1021.
6. SAS Institute. SAS/STAT Software Version 9.2. Cary, NC: SAS Institute; 2000-2008.
7. R Foundation for Statistical Computing. R Version 2.14.1. Vienna, Austria: R Foundation for Statistical Computing; 2011:12-22.
8. Trial to Reduce Alloimmunization to Platelets Study Group. Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions. N Engl J Med. 1997;337(26):1861- 1869.
9. Slichter SJ. Relationship between platelet count and bleeding risk in thrombocytopenic patients. Transfus Med Rev. 2004;18(2):153-167. (Pubitemid 38962484)
10. Heddle NM, Cook RJ, Sigouin C, Slichter SJ, Murphy M, Rebulla P. A descriptive analysis of international transfusion practice and bleeding outcomes in patients with acute leukemia. Transfusion. 2006;46(6):903-911. (Pubitemid 43800908)
11. U.S. Department of Health and Human Services. The 2009 National Blood Collection and Utilization Survey. Washington, DC: US Department of Health and Human Services; 2011.
12. Heddle NM, Arnold DM, Boye D, Webert KE, Resz I, Dumont LJ. Comparing the efficacy and safety of apheresis and whole blood-derived platelet transfusions: a systematic review. Transfusion. 2008;48(7):1447-1458.
13. Ogasawara K, Ueki J, Takenaka M, Furihata K. Study on the expression of ABH antigens on platelets. Blood. 1993;82(2):993-999. (Pubitemid 23221686)
14. Cooling LL, Kelly K, Barton J, Hwand D, Koerner TA, Olson JD. Determinants of ABH expression on human blood platelets. Blood. 2005;105(8):3356-3364.
15. Shehata NS, Tinmouth A, Naglie G, Freedman J, Wilson K. ABO-identical versus nonidentical platelet transfusion: a systematic review. Transfusion. 2009;49(11):2442-2453.
16. Blumberg N, Heal JM, Liesveld JL, Phillips GL, Rowe JM. Platelet transfusions and survival in adults with acute leukemia. Leukemia. 2008;22(3):631-635. (Pubitemid 351386735)
17. Heal JM, Blumberg N, Kirkley SA, DiPersion JF, Rapoport AP, Rowe JM. Leukocyte reduced transfusions of ABO-identical platelets and clinical outcomes in autologous bone marrow transplantation for lymphoma. Bone Marrow Transplant. 1994;14(6):943-948.
18. Heal JM, Kenmotsu N, Rowe JM, Blumberg N. A possible survival advantage in adults with acute leukemia receiving ABO-identical platelet transfusions. Am J Hematol. 1994;45(2):189-190. (Pubitemid 24092591)
19. Carr R, Hutton JL, Jenkins JA, Lucas GF, Amphlett NW. Transfusion of ABO-mismatched platelets leads to early platelet refractoriness. Br J Haematol. 1990;75(3):408-413. (Pubitemid 20233287)
20. Klumpp TR, Herman JH, Innis S, et al. Factors associated with response to platelet transfusion following hematopoietic stem cell transplantation. Bone Marrow Transplant. 1996;17(6):1035-1041. (Pubitemid 26235851)
21. Slichter SJ, Davis K, Enright H, et al. Factors affecting post-transfusion platelet increments, platelet refractoriness, and platelet transfusion intervals in thrombocytopenic patients. Blood. 2005;105(10):4106- 4114. (Pubitemid 40656162)
22. Schiffer CA, Lee EJ, Ness PM, Reilly J. Clinical evaluation of platelet concentrates stored for 1 to 5 days. Blood. 1986;67(6):1591-1594. (Pubitemid 16075961)
23. Leach MF, AuBuchon JP. Effect of storage time on clinical efficacy of single-donor platelets. Transfusion. 1993;33(8):661-664. (Pubitemid 23237597)